Researchers conducted a meta-analysis to investigate the potential relationship between screen usage and autism spectrum disorders (ASD).
Ascidian Therapeutics raises $40m to advance drug development
Ascidian’s lead programme is an RNA exon editor, which can potentially prevent the progression of ABCA4 retinopathies. Credit: fizkes / Shutterstock.com. Ascidian Therapeutics has raised $40m